The remote patient monitoring system is a subclass of telehealth that is designed to deliver healthcare services at the distance. These are typically medical devices deployed at home that transmits vital signs through a data hub, or a desktop console. The data is stored via server-side systems which is then eventually retrieved by caregivers and providers
The remote patient monitoring system focuses on the management of various chronic diseases and infectious diseases. They support patient’s healthcare journey and provide patient’s health data to clinicians and caregivers enabling them to personalize their treatment and meet all the patient's needs to avoid any complications. In addition to this, it also enables patients to take control of their care alongside the physicians and caregivers
Also Read: http://www.marketwatch.com/story/lurasidone-hydrochloride-api-marke...

The rising worldwide demand for remote patient monitoring systems is because of the changing traditional medical protocols and rising investments in telehealth solutions. The increased focus on preventive healthcare, technological advancement in remote healthcare, and the need to reduce surging medical costs are some factors driving the growth of remote patient monitoring systems across the world. Another factor contributing towards the growth of this market is the rising chronic diseases incidences and growing ageing population. In addition to this, the worldwide adoption of virtual and home health technologies owing to the number of canceled appointments and deferred care amidst the novel coronavirus outbreak has further augmented the worldwide demand for remote patient monitoring systems
However, some of the restraints in the market include a lack of awareness and regulatory variations across countries. In addition to this, healthcare fraud and resistance from the conventional healthcare system are impeding the growth of this market all over the world
Also Read: http://www.marketwatch.com/story/optocouplers-market-research-repor...

Based on product, the market is divided into vital sign monitors and specialized monitors. The vital sign monitors are further segmented into temperature monitor, blood pressure monitor, pulse oximeter, heart rate monitor, respiratory rate monitor and brain monitor. In contrast, specialized monitors is sub-segmented into blood glucose monitor, cardiac rhythm monitor, anesthesia monitor, respiratory monitor, fetal heart monitor, multiparameter monitor and others
The specialized monitors segment accounted for the major market share owing to their ability to monitor vital parameters that helps in managing various chronic diseases. However, the vital sign monitors segment is anticipated to grow substantially in the projected timeframe
The application segment is fragmented into diabetes, cardiovascular diseases, sleep disorders, weight management & fitness tracking and other applications. The diabetes segment dominated the market owing to the growing prevalence of diabetic population all over the world. However, cardiovascular diseases accounted for second highest market share
Based on end-user, the remote patient monitoring system market is divided into Hospitals/clinics, home care settings and others. The hospitals/clinics segment held the major market share. Apart from this, home care settings segment is also expected to grow significantly in the forthcoming years
Also Read: http://www.marketwatch.com/story/remote-patient-monitoring-system-m...

Some of the major players operating in the market include F. Hoffmann-La Roche, Medtronic, GE Healthcare, Abbott Laboratories, Omron Corporation, Johnson & Johnson, American Telecare, Philips Healthcare, Boston Scientific Corporation, Biotelemetry, etc. Several M&A’s along with partnerships have been undertaken by these players to boost their presence in different regions
1 MARKET INTRODUCTION
1.1 Market Definitions
1.2 Objective of the Study
1.3 Limitation
1.4 Stake Holders
1.5 Currency Used in Report
1.6 Scope of the Remote Patient Monitoring System Market Study
2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1 Research Methodology for the Global Remote Patient Monitoring System Market
2.1.1 Main Objective of the Global Remote Patient Monitoring System Market
3 MARKET SYNOPSIS
4 EXECUTIVE SUMMARY
5 TOP START-UPS UNDER REMOTE PATIENT MONITORING SYSTEM SECTOR
6 REMOTE PATIENT MONITORING SYSTEM AMID COVID-19
7 GLOBAL REMOTE PATIENT MONITORING SYSTEM MARKET REVENUE (USD BN), 2021-2027F
8 MARKET INSIGHTS BY PRODUCT
8.1 Vital Sign Monitors
8.1.1 Temperature Monitor
8.1.2 Blood Pressure Monitor
8.1.3 Pulse Oximeters
8.1.4 Heart Rate Monitor (ECG)
8.1.5 Respiratory Rate Monitor
8.1.6 Brain Monitor (EEG)
8.2 Specialized Monitors
8.2.1 Blood Glucose Monitor
8.2.2 Cardiac Rhythm Monitor
8.2.3 Anesthesia Monitor
8.2.4 Respiratory Monitor
8.2.5 Fetal Heart Monitor
8.2.6 Multiparameter Monitor
8.2.7 Others
9 MARKET INSIGHTS BY APPLICATION
9.1 Diabetes
9.2 Cardiovascular Diseases
9.3 Sleep Disorders
9.4 Weight Management & Fitness Tracking
9.5 Other Applications
10 MARKET INSIGHTS BY END-USER
10.1 Hospitals/Clinics
10.2 Home Care Settings
10.3 Others
11 MARKET INSIGHTS BY REGION
11.1 North America Remote Patient Monitoring System Market
11.1.1 United States
11.1.2 Canada
11.1.3 Rest of North America
11.2 Europe Remote Patient Monitoring System Market
11.2.1 Germany
11.2.2 France
11.2.3 United Kingdom
11.2.4 Italy
11.2.5 Spain
11.2.6 Rest of Europe
11.3 Asia Pacific Remote Patient Monitoring System Market
11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 Rest of Asia Pacific
11.4 Rest of World Remote Patient Monitoring System Market
12 REMOTE PATIENT MONITORING SYSTEM MARKET DYNAMICS
12.1 Market Drivers
12.2 Market Challenges
12.3 Impact Analysis
13 REMOTE PATIENT MONITORING SYSTEM MARKET OPPORTUNITIES
14 REMOTE PATIENT MONITORING SYSTEM MARKET TRENDS
15 LEGAL & REGULATORY FRAMEWORK
16 DEMAND AND SUPPLY SIDE ANALYSIS
16.1 Demand Side Analysis
16.2 Supply Side Analysis
16.2.1 Top Product Launches
16.2.2 Top Business Partnerships
16.2.3 Top Business Expansions, Investments and Divestitures
16.2.4 Top Merger and Acquisitions
17 VALUE CHAIN ANALYSIS
18 COMPETITIVE SCENARIO
18.1 Porter’s Five Forces Analysis
18.1.1 Bargaining power of Supplier
18.1.2 Bargaining power of Buyer
18.1.3 Industry Rivalry
18.1.4 Availability of Substitute
18.1.5 Threat of new Entrants
18.2 Competitive Landscape
18.2.1 Company Shares, By Revenue
19 COMPANY PROFILED
19.1 Medtronic
19.2 F Hoffmann-La Roche
19.3 GE Healthcare
19.4 Abbott Laboratories
19.5 Omron Corporation
19.6 Johnson & Johnson
19.7 American Telecare
19.8 Philips Healthcare
19.9 Boston Scientific Corporation
19.10 Biotelemetry, Inc.
20 DISCLAIMER ----
CONTACT DETAILS :

[email protected]
+44 203 500 2763
+1 62 825 80070
971 0503084105